• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性炎症性肌病患者伴或不伴进行性纤维化表型的间质性肺病:一项大型多中心队列研究的数据。

Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort.

机构信息

Rheumatology Unit, Department of Medicine-DIMED, Padova University Hospital, Padova, Italy.

Respiratory Disease Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova University Hospital, Padova, Italy.

出版信息

RMD Open. 2023 Aug;9(3). doi: 10.1136/rmdopen-2023-003121.

DOI:10.1136/rmdopen-2023-003121
PMID:37541742
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10407351/
Abstract

OBJECTIVES

Patients with connective tissue diseases can develop interstitial lung disease (ILD), leading to a progressive fibrosing ILD (PF-ILD) phenotype in some cases. We aimed to investigate the occurrence of PF-ILD in idiopathic inflammatory myopathies (IIMs), and factors potentially predicting this phenotype. Secondary aims were to assess the radiological pattern and factors associated with IIMs-ILD.

METHODS

Patients with IIMs from our multicentric prospective cohort were retrospectively evaluated. Data were recorded at IIMs and ILD diagnosis, and during follow-up. Patients with ILD were classified according to the predominant high-resolution CT (HRCT) pattern: non-specific interstitial pneumonia (NSIP), usual interstitial pneumonia (UIP) and organising pneumonia (OP). PF-ILD was defined according to the 2022 American Thoracic Society (ATS), European Respiratory Society (ERS), Japanese Respiratory Society (JRS) and Latin American Thoracic Society (ALAT) guidelines. Univariate and multivariate analyses were performed to identify factors associated to ILD and to PF-ILD.

RESULTS

Of 253 patients with IIMs, 125 (49%) had ILD: 99 (78%) at IIMs diagnosis and 26 (22%) during follow-up (21/26 within 5 years). Multivariate analysis identified anti-Jo-1, anti-MDA5, anti-Ro52, high score on manual muscle test, mechanic's hands and Raynaud's phenomenon as independently associated with ILD. The predominant HRCT pattern was NSIP (50% of patients), followed by UIP (28%) and OP (22%). At 1-year follow-up, PF-ILD occurred in 18% of IIMs-ILD. PF-ILD was predicted by anti-MDA5, heliotropic rash, xerostomia and xerophthalmia at univariate but not at multivariate analysis.

CONCLUSION

Patients with IIM should be carefully screened for ILD at IIMs diagnosis and yearly during follow-up. All patients with IIMs-ILD should be carefully monitored to capture ILD progression since a consistent proportion of them are expected to develop PF-ILD.

摘要

目的

结缔组织疾病患者可发生间质性肺疾病(ILD),某些情况下导致进行性纤维化ILD(PF-ILD)表型。本研究旨在探讨特发性炎性肌病(IIM)中 PF-ILD 的发生情况,以及可能预测该表型的因素。次要目的是评估与 IIM-ILD 相关的影像学模式和因素。

方法

对来自我们多中心前瞻性队列的 IIM 患者进行回顾性评估。在 IIM 和ILD 诊断时以及随访期间记录数据。根据主要高分辨率 CT(HRCT)模式对ILD 患者进行分类:非特异性间质性肺炎(NSIP)、寻常型间质性肺炎(UIP)和机化性肺炎(OP)。根据 2022 年美国胸科学会(ATS)、欧洲呼吸学会(ERS)、日本呼吸学会(JRS)和拉丁美洲胸科学会(ALAT)指南,将 PF-ILD 定义为 UIP 以外的所有 ILD。采用单变量和多变量分析来识别与ILD 和 PF-ILD 相关的因素。

结果

在 253 例 IIM 患者中,125 例(49%)有ILD:99 例(78%)在 IIM 诊断时,26 例(22%)在随访时(26 例中有 21 例在 5 年内)。多变量分析确定抗-Jo-1、抗-MDA5、抗 Ro52、手动肌肉测试评分高、技工手和雷诺现象与ILD 独立相关。主要 HRCT 模式为 NSIP(50%的患者),其次是 UIP(28%)和 OP(22%)。在 1 年随访时,18%的 IIM-ILD 患者发生 PF-ILD。PF-ILD 在单变量分析中由抗-MDA5、向心性皮疹、口干和眼干预测,但在多变量分析中未预测。

结论

在 IIM 诊断时和随访期间应每年仔细筛查 IIM 患者的ILD。所有 IIM-ILD 患者都应密切监测以捕捉ILD 进展,因为预计其中相当一部分患者会发展为 PF-ILD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e5/10407351/adf247a98db4/rmdopen-2023-003121f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e5/10407351/adf247a98db4/rmdopen-2023-003121f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e5/10407351/adf247a98db4/rmdopen-2023-003121f01.jpg

相似文献

1
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort.特发性炎症性肌病患者伴或不伴进行性纤维化表型的间质性肺病:一项大型多中心队列研究的数据。
RMD Open. 2023 Aug;9(3). doi: 10.1136/rmdopen-2023-003121.
2
Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies.自然杀伤细胞耗竭对特发性炎症性肌病进行性纤维性间质性肺病的预测意义。
Front Immunol. 2024 Apr 30;15:1404828. doi: 10.3389/fimmu.2024.1404828. eCollection 2024.
3
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis.特发性炎性肌病相关间质性肺病的预测特征和临床表现。
Clin Rev Allergy Immunol. 2021 Feb;60(1):87-94. doi: 10.1007/s12016-020-08814-5. Epub 2020 Nov 3.
4
Myositis-associated Interstitial Lung Disease: Clinical Characteristics and Factors Related to Pulmonary Function Improvement: A Latin-American Multicenter Cohort Study.肌肉炎相关间质性肺病:临床特征和与肺功能改善相关的因素:一项拉丁美洲多中心队列研究。
Reumatol Clin (Engl Ed). 2022 May;18(5):293-298. doi: 10.1016/j.reumae.2020.12.006.
5
CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies.CCL18作为特发性炎性肌病患者间质性肺疾病(ILD)和进行性纤维化ILD的生物标志物
Diagnostics (Basel). 2023 May 12;13(10):1715. doi: 10.3390/diagnostics13101715.
6
Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort.皮肌炎中无肌炎特异性和肌炎相关自身抗体相关的间质性肺病:来自单一队列的 72 例患者系列研究。
Front Immunol. 2022 May 6;13:879266. doi: 10.3389/fimmu.2022.879266. eCollection 2022.
7
Quantitative interstitial lung disease scores in idiopathic inflammatory myopathies: longitudinal changes and clinical implications.特发性炎性肌病的定量肺间质疾病评分:纵向变化及其临床意义。
Rheumatology (Oxford). 2023 Nov 2;62(11):3690-3699. doi: 10.1093/rheumatology/kead122.
8
Predictive factors of mortality in rheumatoid arthritis-associated interstitial lung disease analysed by modified HRCT classification of idiopathic pulmonary fibrosis according to the 2018 ATS/ERS/JRS/ALAT criteria.根据2018年美国胸科学会(ATS)/欧洲呼吸学会(ERS)/日本呼吸学会(JRS)/拉丁美洲胸科协会(ALAT)标准,通过对特发性肺纤维化的改良高分辨率计算机断层扫描(HRCT)分类分析类风湿关节炎相关间质性肺疾病死亡率的预测因素。
J Thorac Dis. 2019 Dec;11(12):5247-5257. doi: 10.21037/jtd.2019.11.73.
9
Decreased Th1 Cells and Increased Th2 Cells in Peripheral Blood Are Associated with Idiopathic Inflammatory Myopathies Patients with Interstitial Lung Disease.外周血中Th1细胞减少和Th2细胞增加与特发性炎症性肌病合并间质性肺疾病患者相关。
Inflammation. 2023 Feb;46(1):468-479. doi: 10.1007/s10753-022-01747-5. Epub 2022 Oct 20.
10
Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.特发性炎性肌病:间质性肺疾病的CT特征及其与肌炎特异性自身抗体的关联
Eur Radiol. 2022 May;32(5):3480-3489. doi: 10.1007/s00330-021-08411-w. Epub 2022 Jan 13.

引用本文的文献

1
High-Resolution CT Findings in Interstitial Lung Disease Associated with Connective Tissue Diseases: Differentiating Patterns for Clinical Practice-A Systematic Review with Meta-Analysis.结缔组织病相关间质性肺疾病的高分辨率CT表现:临床实践中的鉴别模式——一项荟萃分析的系统评价
J Clin Med. 2025 Aug 31;14(17):6164. doi: 10.3390/jcm14176164.
2
Advancements in mesenchymal stromal cells for treating connective tissue disease-associated interstitial lung disease: from basic research to clinical application.间充质基质细胞治疗结缔组织病相关间质性肺病的进展:从基础研究到临床应用
Stem Cell Res Ther. 2025 Aug 26;16(1):457. doi: 10.1186/s13287-025-04597-8.
3

本文引用的文献

1
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化(更新版)和成人进展性肺纤维化:美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2022 May 1;205(9):e18-e47. doi: 10.1164/rccm.202202-0399ST.
2
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.抗拓扑异构酶 I 抗体阳性的局限性皮肤系统性硬化症患者的表型:来自 EUSTAR 队列的数据。
Rheumatology (Oxford). 2022 Nov 28;61(12):4786-4796. doi: 10.1093/rheumatology/keac188.
3
Serum ferritin as a specific biomarker of anti-MDA5-interstitial lung disease: a multicenter, case-control study in observational and validation datasets.
血清铁蛋白作为抗MDA5间质性肺病的特异性生物标志物:一项在观察性和验证性数据集中开展的多中心病例对照研究
Rheumatol Int. 2025 Jul 15;45(8):171. doi: 10.1007/s00296-025-05918-z.
4
Integration of clinical and serological biomarkers in a nomogram for predicting interstitial lung disease in idiopathic inflammatory myopathies.临床和血清生物标志物在预测特发性炎性肌病间质性肺病的列线图中的整合。
BMC Rheumatol. 2025 Jul 1;9(1):73. doi: 10.1186/s41927-025-00534-7.
5
Comparison of Chest High-Resolution Computed Tomography Findings in Patients with Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive and Antibody-Negative Progressive Pulmonary Fibrosis with Polymyositis/Dermatomyositis.抗黑色素瘤分化相关基因5抗体阳性和抗体阴性的多肌炎/皮肌炎相关进行性肺纤维化患者胸部高分辨率计算机断层扫描结果的比较
J Clin Med. 2025 Feb 27;14(5):1601. doi: 10.3390/jcm14051601.
6
Integrated analysis of dermatomyositis reveals heterogeneous immune infiltration and interstitial lung disease-associated endotype.皮肌炎的综合分析揭示了异质性免疫浸润和间质性肺疾病相关的内型。
Arthritis Res Ther. 2025 Feb 8;27(1):26. doi: 10.1186/s13075-025-03494-y.
7
Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseases.磷酸二酯酶-4抑制作为治疗风湿性疾病相关间质性肺疾病的策略的理论依据。
RMD Open. 2024 Dec 23;10(4):e004704. doi: 10.1136/rmdopen-2024-004704.
8
A Practical Multidisciplinary Approach to Identifying Interstitial Lung Disease in Systemic Autoimmune Rheumatic Diseases: A Clinician's Narrative Review.一种识别系统性自身免疫性风湿性疾病中间质性肺疾病的实用多学科方法:临床医生的叙述性综述
Diagnostics (Basel). 2024 Nov 27;14(23):2674. doi: 10.3390/diagnostics14232674.
9
Myositis-Associated Interstitial Lung Disease: The Experience of a Tertiary Center.肌炎相关间质性肺疾病:一家三级中心的经验
J Clin Med. 2024 Oct 12;13(20):6085. doi: 10.3390/jcm13206085.
10
Poor prognostic factors for relapse of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies after combination therapy.抗氨酰-tRNA 合成酶抗体相关间质性肺病经联合治疗后复发的不良预后因素。
Front Immunol. 2024 Sep 13;15:1407633. doi: 10.3389/fimmu.2024.1407633. eCollection 2024.
Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management.
系统性自身免疫性风湿病的胸部受累:发病机制与治疗。
Clin Rev Allergy Immunol. 2022 Dec;63(3):472-489. doi: 10.1007/s12016-022-08926-0. Epub 2022 Mar 18.
4
Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype.具有进行性表型的慢性纤维性间质性肺疾病的患病率和预后。
Respirology. 2022 May;27(5):333-340. doi: 10.1111/resp.14245. Epub 2022 Mar 15.
5
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry.前瞻性登记研究中进行性纤维化间质性肺疾病的患病率及特征
Eur Respir J. 2022 Oct 6;60(4). doi: 10.1183/13993003.02571-2021. Print 2022 Oct.
6
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies.非亚洲人群抗 MDA5 抗体阳性的临床谱时间过程。
Clin Exp Rheumatol. 2022 Feb;40(2):274-283. doi: 10.55563/clinexprheumatol/di1083. Epub 2022 Feb 16.
7
Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease.抗纤维化药物在特发性炎性肌病相关间质性肺疾病管理中的作用
Ther Adv Musculoskelet Dis. 2021 Dec 9;13:1759720X211060907. doi: 10.1177/1759720X211060907. eCollection 2021.
8
High-Resolution CT Findings of Myositis-Related Interstitial Lung Disease.特发性肌炎相关间质性肺病的高分辨率 CT 表现
Medicina (Kaunas). 2021 Jul 6;57(7):692. doi: 10.3390/medicina57070692.
9
The burden of progressive fibrotic interstitial lung disease across the UK.英国进行性纤维性间质性肺疾病的负担。
Eur Respir J. 2021 Jul 8;58(1). doi: 10.1183/13993003.00221-2021. Print 2021 Jul.
10
Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study.尼达尼布治疗特发性炎症性肌病相关间质性肺病的疗效和耐受性:一项试点研究。
Front Med (Lausanne). 2021 Feb 3;8:626953. doi: 10.3389/fmed.2021.626953. eCollection 2021.